Yatim A, Youssefian L, Idani A, Mourelatos H, Alipour Olyaei N, Habibi L, Peel JN, Gaballa M, Kim C, Lee D, Le Floc'h C, Chan YH, Martin-Fernandez M, Pelletier L, Nakajima K, Fayand A, Momenilandi M, Seeleuthner Y, Chaldebas M, Saeidian AH, Mahmoudi H, Nikbakht N, Deswarte C, Kerrouche N, Sahel H, Parvaneh N, Tamizifar B, Sherkat R, Chanal J, Firooz A, Alizadeh Z, Lorenzo-Diaz L, Mariaggi AA, Ogishi M, Diep A, Hammadi B, Kerrouche N, Rinchai D, Sedighzadeh S, Mehrjooy S, Akrami SM, Lenormand C, Radosavljevic M, Rosain J, Zhang SY, Boisson B, Zhang P, Boisson-Dupuis S, Krueger JG, Prétet JL, Waterboer T, Pourpak Z, Fazlollahi MR, Abel L, Bogunovic D, Shahrooei M, Cobat A, Carapito R, Molitor A, Vahidnezhad H, Béziat V, Bahram S, Jouanguy E, Casanova JL

Sci Immunol. 2026 02 27;11(116):eadz8360

[Development and distribution of an inter-laboratory comparison test for HPV testing].

Poy M, Jacquot K, Gross S, Lepiller Q, Prétet JL, Hpv GD

Virologie (Montrouge). 2026 02 1;30(1):63-69

Phenotypic effect of the mutations H78Y and L83V in the E6 protein of human papillomavirus.

Di Domizio N, Debernardi A, Olivier M, Bôle-Richard E, Caël B, Gaillot S, Prétet JL, Lepiller Q

Arch Virol. 2025 12 18;171(1):25

Reproducibility of HPV Testing With Two Versions of the Papilloplex High-Risk HPV Assay.

Chung PYJ, Baraquin A, Jacquot K, Tkachenka Y, Puget L, Lepiller Q, Broeck DV, Prétet JL, Arbyn M

J Med Virol. 2025 11;97(11):e70680

High-Risk Human Papillomavirus Positive-Negative-Positive Infection Pattern Revealed Infection Below the Screening Test Cutoff.

Di Domizio N, Bertin C, Ramanah R, Algros MP, Lepiller Q, Prétet JL

J Low Genit Tract Dis. 2025 10 1;29(4):342-347

Management of women with abnormal cervical cytology: Update of French guidelines after the implementation of HPV screening.

Brun JL, Bergeron C, Averous G, Ardaens K, Aynaud O, Baffet H, Bouquet S, Canlorbe G, Charpentier C, Clavel C, Cochand-Priollet B, Courtade M, Frigenza M, Garrigue I, Gondry J, Hernandez I, Hocquemiller R, Huynh B, Judlin P, Bail Carval KL, Lecointre L, Leveque J, Maruani J, Mergui JL, Mignot S, Monsonego J, Mousteou F, Payan C, Paysant S, Piclet H, Pourcelot AG, Pretet JL, Raulic P, de Reilhac P, Riethmuller D, Thomas N, Weyl A, Carcopino X

Eur J Obstet Gynecol Reprod Biol. 2025 08 22;314:114661

A multicentre pragmatic randomized controlled trial comparing 50% salicylic acid, liquid nitrogen, 5% 5-fluorouracil cream, and 5% imiquimod cream in previously treated plantar warts. The VRAIE (VeRrues plAntaIres en villE) study.

Chanal J, Aubin F, Buffière I, Perrière C, Bocquet H, Aubin A, Farcet Y, Ludmann C, Duboz A, Marco-Bonnet J, Maury C, Tremeau-Martinage C, Hubert-Asso AM, Coustou D, Heudes AM, Kemula M, Beylot-Barry M, Tétart F, Eche-Dejoie A, Duvochel AM, Baspeyras M, Penso-Assathiany D, Amici JM, Toussaint H, Neculaita L, Makhlouf W, Mboup B, Pizzi N, Jouis V, Vacher Y, Prétet JL, Vicaut E, Chosidow O

Ann Dermatol Venereol. 2025 07 30;152(3):103406

The Human Papillomavirus (HPV) Laboratory e-Manual: A comprehensive guide for HPV testing and research.

Arroyo Mühr LS, Eklund C, Lagheden C, Correa RM, Fellner MD, Picconi MA, Songur N, Gultekin M, Cuschieri K, Prétet JL, Lepiller Q, Baraquin A, Silling S, Søreng K, Stosic M, Presthus GK, Arbyn M, Peeters M, Gucht SV, Padalko E, Chin T, Kehoe K, Pereira AR, Redzic N, Vanden Broeck D, Molano M, Murray GL, Garland SM, Pinto LA, Wilkinson DE, Poljak M, Dillner J

J Clin Virol. 2025 07 10;179:105834

Detection of alpha-HPV types in cutaneous squamous cell carcinoma associated with markers of carcinogenesis: a retrospective study.

Brunet-Possenti F, Weiss M, Prétet JL, Deschamps L, Descamps V, Halimi C, Descamps D, Ghosn J, Guilbaud R, Charpentier C, Ferré VM

Clin Exp Dermatol. 2025 06 20;:

Human papillomavirus genotype distribution among high-grade cervical lesions in French women born between 1972 and 1993.

Lenoir P, Guillet J, Desmarets M, Baraquin A, Ramanah R, Rousse J, Mougin C, Lepiller Q, Prétet JL,

J Gynecol Obstet Hum Reprod. 2025 03 21;:102945

[Management of women with abnormal cervical cytology: Update of INCa recommendations after the implementation of HPV screening].

Brun JL, Bergeron C, Averous G, Ardaens K, Aynaud O, Baffet H, Bouquet S, Canlorbe G, Charpentier C, Clavel C, Cochand-Priollet B, Courtade M, Frigenza M, Garrigue I, Gondry J, Hernandez I, Hocquemiller R, Huynh B, Judlin P, Le Bail-Carval K, Lecointre L, Leveque J, Maruani J, Mergui JL, Mignot S, Monsonego J, Mousteou F, Payan C, Paysant S, Piclet H, Pourcelot AG, Pretet JL, Raulic P, de Reilhac P, Riethmuller D, Thomas N, Weyl A, Carcopino X

Gynecol Obstet Fertil Senol. 2025 02;53(2):54-75

Viral and immune dynamics of genital human papillomavirus infections in young women with high temporal resolution.

Tessandier N, Elie B, Boué V, Selinger C, Rahmoun M, Bernat C, Grasset S, Groc S, Bedin AS, Beneteau T, Bonneau M, Graf C, Jacobs N, Kamiya T, Kerioui M, Lajoie J, Melki I, Prétet JL, Reyné B, Schlecht-Louf G, Sofonea MT, Supplisson O, Wymant C, Foulongne V, Guedj J, Hirtz C, Picot MC, Reynes J, Tribout V, Tuaillon É, Waterboer T, Segondy M, Bravo IG, Boulle N, Murall CL, Alizon S

PLoS Biol. 2025 01;23(1):e3002949

IL-7-dependent and -independent lineages of IL-7R-dependent human T cells.

Arango-Franco CA, Ogishi M, Unger S, Delmonte OM, Orrego JC, Yatim A, Velasquez-Lopera MM, Zea-Vera AF, Bohlen J, Chbihi M, Fayand A, Sánchez JP, Rojas J, Seeleuthner Y, Le Voyer T, Philippot Q, Payne KJ, Gervais A, Erazo-Borrás LV, Correa-Londoño LA, Cederholm A, Gallón-Duque A, Goncalves P, Doisne JM, Horev L, Charmeteau-de Muylder B, Álvarez JÁ, Arboleda DM, Pérez-Zapata L, Vásquez-Echeverri E, Moncada-Vélez M, López JA, Caicedo Y, Palterer B, Patiño PJ, Montoya CJ, Chaldebas M, Zhang P, Nguyen T, Ma CS, Jeljeli M, Alzate JF, Cabarcas F, Khan T, Rinchai D, Prétet JL, Boisson B, ,Marr N, Ibrahim R, Molho-Pessach V, Boisson-Dupuis S, Kiritsi D, Barata JT, Landegren N, Neven B, Abel L, Lisco A, Béziat V, Jouanguy E, Bustamante J, Di Santo JP, Tangye SG, Notarangelo LD, Cheynier R, Natsuga K, Arias AA, Franco JL, Warnatz K, Casanova JL, Puel A

J Clin Invest. 2024 10 1;134(19):

The Sansure® Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high-risk HPV.

Prétet JL, Baraquin A, Chung PYJ, Puget L, Dhillon SK, Tkachenka Y, Jacquot K, Lepiller Q, Broeck DV, Arbyn M

J Med Virol. 2024 10;96(10):e29961

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.

Arbyn M, Cuschieri K, Bonde J, Schuurman R, Cocuzza C, Broeck DV, Zhao FH, Rezhake R, Gultekin M, de Sanjosé S, Canfell K, Hawkes D, Saville M, Hillemanns P, Dillner J, Berkhof J, Prétet JL, Gheit T, Clifford G, Basu P, Almonte M, Wentzensen N, Poljak M

J Med Virol. 2024 09;96(9):e29881

The level of expression of HPV16 early transcripts is not associated with the natural history of cervical lesions.

Jacquin E, Saunier M, Lepiller Q, Monnien F, Mauny F, Ramanah R, Carcopino X, Riethmuller D, Mougin C, Prétet JL

J Med Virol. 2024 09;96(9):e29875

Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay.

Chung PYJ, Dhillon SK, Baraquin A, Tkachenka Y, Jacquot K, Prétet JL, Broeck DV, Arbyn M

J Med Virol. 2024 06;96(6):e29688

FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice.

Momenilandi M, Lévy R, Sobrino S, Li J, Lagresle-Peyrou C, Esmaeilzadeh H, Fayand A, Le Floc'h C, Guérin A, Mina ED, Shearer D, Delmonte OM, Yatim A, Mulder K, Mancini M, Rinchai D, Denis A, Neehus AL, Balogh K, Brendle S, Rokni-Zadeh H, Changi-Ashtiani M, Seeleuthner Y, Deswarte C, Bessot B, Cremades C, Materna M, Cederholm A, Ogishi M, Philippot Q, Beganovic O, Ackermann M, Wuyts M, Khan T, Fouéré S, Herms F, Chanal J, Palterer B, Bruneau J, Molina TJ, Leclerc-Mercier S, Prétet JL, Youssefian L, Vahidnezhad H, Parvaneh N, Claeys KG, Schrijvers R, Luka M, Pérot P, Fourgeaud J, Nourrisson C, Poirier P, Jouanguy E, Boisson-Dupuis S, Bustamante J, Notarangelo LD, Christensen N, Landegren N, Abel L, Marr N, Six E, Langlais D, Waterboer T, Ginhoux F, Ma CS, Tangye SG, Meyts I, Lachmann N, Hu J, Shahrooei M, Bossuyt X, Casanova JL, Béziat V

Cell. 2024 05 2;:

Urinary cytomegalovirus excretion: the unresolved issues.

Puget L, Node J, Caël B, Bamoulid J, Coaquette A, Prétet JL, Lepiller Q

Ann Pharm Fr. 2024 03 14;:

Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.

Prétet JL, Arroyo Mühr LS, Cuschieri K, Fellner MD, Correa RM, Picconi MA, Garland SM, Murray GL, Molano M, Peeters M, Van Gucht S, Lambrecht C, Broeck DV, Padalko E, Arbyn M, Lepiller Q, Brunier A, Silling S, Søreng K, Christiansen IK, Poljak M, Lagheden C, Yilmaz E, Eklund C, Thapa HR, Querec TD, Unger ER, Dillner J

J Clin Virol. 2024 02 20;171:105657

Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR-HPV assay (Abbott).

Node J, Dor F, Puget L, Ramanah R, Cot S, Bibeau F, Di Domizio N, Prétet JL, Lepiller Q

J Med Virol. 2024 02;96(2):e29465

Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice.

Spindler L, Etienney I, Abramowitz L, de Parades V, Pigot F, Siproudhis L, Adam J, Balzano V, Bouchard D, Bouta N, Bucau M, Carlo A, Chanal J, Charpentier C, Clifford G, Draullette M, Fathallah N, Ferré V, Fléjou JF, Fouéré S, Higuero T, Kassouri L, Kurt S, Laurain A, Leclerc E, Lepiller Q, Lesage AC, Mège D, Ménard A, Merle P, Mortreux P, Noël C, Péré H, Prétet JL, Roland D, Staumont G, Tracanelli L, Vuitton L, Wylomanski S, Zaegel-Faucher O,

Tech Coloproctol. 2024 01 10;28(1):23

Comparison of high-risk HPV detection by the AmpFire® HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen).

Koussouri A, Baraquin A, Desmarets M, Diallo K, Puget L, Lepiller Q, Prétet JL

Mol Biol Rep. 2024 01 2;51(1):52

Anogenital distribution of mucosal HPV in males and females before and after renal transplantation.

Prétet JL, Touzé A, Pazart L, Boiteux G, Fournier V, Vidal Statistical Analysis C, Arnold F, Ducloux D, Lepiller Data Analysis Q, Mougin C

Infect Dis Now. 2023 11 8;:104830

Anal and oropharyngeal HPV distribution in HIV-negative multipartner MSM using self-sampling kits for HIV and sexually transmitted infection screening.

Prétet JL, Baraquin A, Barret AS, Bercot B, Rahib D, Lydié N, Pépin-Puget L, Lepiller Q

J Med Virol. 2023 09;95(9):e29068

Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward - a meeting report.

Waheed DE, Olivier CW, Riethmuller D, Franco EL, Prétet JL, Baay M, Munoz N, Vorsters A

BMC Proc. 2023 08 3;17(Suppl 11):18

Human papilloma virus-16-specific CD8+ T-cell expansions characterize different clinical forms of lichen planus and not lichen sclerosus et atrophicus.

Viguier M, Pérals C, Poirier B, Battistella M, Aubin F, Bachelez H, Prétet JL, Gheit T, Tommasino M, Touzé A, Gougeon ML, Fazilleau N

Exp Dermatol. 2023 03 15;:

Human cytomegalovirus-viruria in hematopoietic stem cell transplant recipients: context and impact.

Puget L, Berceanu A, Node J, Coaquette A, Overs A, Herbein G, Prétet JL, Daguindau E, Lepiller Q

Infect Dis Now. 2023 01 23;:104651

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial.

Debernardi A, Meurisse A, Prétet JL, Guenat D, Monnien F, Spehner L, Vienot A, Roncarati P, André T, Abramowitz L, Molimard C, Mougin C, Herfs M, Kim S, Borg C

Front Oncol. 2022 10 14;12:941676

[New recommendations for cervical cancer screening in France].

Baraquin A, Pépin L, Floerchinger P, Lepiller Q, Prétet JL

Ann Pharm Fr. 2022 09 20;:

Longitudinal follow-up of HPV16 sequence after cervical infection: low intra-host variation and no correlation with clinical evolution.

Debernardi A, Valot B, Almarcha J, Guenat D, Hocquet D, Algros MP, Riethmuller D, Ramanah R, Mougin C, Prétet JL, Lepiller Q

J Med Virol. 2022 07 7;:

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry.

Selmani Z, Molimard C, Overs A, Bazan F, Chaigneau L, Dobi E, Meneveau N, Mansi L, Paillard MJ, Meynard G, Viot J, Algros MP, Borg C, Feugeas JP, Pivot X, Prétet JL, Curtit E

Sci Rep. 2022 Mar 7;12(1):3617

High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study.

Prétet JL, Dalstein V, Touzé A, Beby-Defaux A, Soussan P, Jacquin É, Birembaut P, Clavel C, Mougin C, Rousseau A, Lacau Saint Guily J,

Clin Exp Med. 2022 Feb 23;:

HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar.

Culié D, Rousseau A, Pretet JL, Lacau Saint Guily J

Eur Arch Otorhinolaryngol. 2021 Oct 18;:

The detection of specific hypermethylated WIF1 and NPY genes in circulating DNA by crystal digital PCR™ is a powerful new tool for colorectal cancer diagnosis and screening.

Overs A, Flammang M, Hervouet E, Bermont L, Pretet JL, Christophe B, Selmani Z

BMC Cancer. 2021 Oct 10;21(1):1092

Repurposing the Hybrid Capture 2 (HC2) screening test for whole-genome sequencing of human papillomaviruses.

Debernardi A, Jarassier W, Soret C, Mougin C, Alizon S, Bravo IG, Guenat D, Prétet JL, Lepiller Q

Arch Virol. 2021 Oct 7;:

HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study.

Baumann A, Henriques J, Selmani Z, Meurisse A, Lepiller Q, Vernerey D, Valmary-Degano S, Paget-Bailly S, Riethmuller D, Ramanah R, Mougin C, Prétet JL

Cancers (Basel). 2021 Aug 18;13(16):

Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients.

Molimard C, L'Huillier V, Overs A, Soret C, Algros MP, Mougin C, Guenat D, Mauvais O, Prétet JL

J Int Med Res. 2021 Jul;49(7):3000605211022534

Successful retrieval of human papillomavirus DNA after a 4.5 year storage on FTA elute cards.

Prétet JL, Baraquin A, Soret C, Rousselot J, Averous G, Fender M, Mougin C, Baldauf JJ

J Virol Methods. 2021 Jun 24;:114218

Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.

Béziat V, Rapaport F, Hu J, Titeux M, Bonnet des Claustres M, Bourgey M, Griffin H, Bandet É, Ma CS, Sherkat R, Rokni-Zadeh H, Louis DM, Changi-Ashtiani M, Delmonte OM, Fukushima T, Habib T, Guennoun A, Khan T, Bender N, Rahman M, About F, Yang R, Rao G, Rouzaud C, Li J, Shearer D, Balogh K, Al Ali F, Ata M, Dabiri S, Momenilandi M, Nammour J, Alyanakian MA, Leruez-Ville M, Guenat D, Materna M, Marcot L, Vladikine N, Soret C, Vahidnezhad H, Youssefian L, Saeidian AH, Uitto J, Catherinot É, Navabi SS, Zarhrate M, Woodley DT, Jeljeli M, Abraham T, Belkaya S, Lorenzo L, Rosain J, Bayat M, Lanternier F, Lortholary O, Zakavi F, Gros P, Orth G, Abel L, Prétet JL, Fraitag S, Jouanguy E, Davis MM, Tangye SG, Notarangelo LD, Marr N, Waterboer T, Langlais D, Doorbar J, Hovnanian A, Christensen N, Bossuyt X, Shahrooei M, Casanova JL

Cell. 2021 Jun 22;:

The Exon Junction Complex core factor eIF4A3 is a key regulator of HPV16 gene expression.

Meznad K, Paget-Bailly P, Jacquin E, Peigney A, Aubin F, Guittaut M, Mougin C, Prétet JL, Baguet A

Biosci Rep. 2021 Mar 24;:

Electrostatic wipes as simple and reliable methods for influenza virus airborne detection.

Marty-Quinternet S, Puget L, Debernardi A, Aubry R, Magy-Bertrand N, Prétet JL, Chirouze C, Bouiller K, Lepiller Q

J Hosp Infect. 2020 Nov 13;:

Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter study.

Bruyere D, Monnien F, Colpart P, Roncarati P, Vuitton L, Hendrick E, Lepinoy A, Luquain A, Pilard C, Lerho T, Molimard C, Maingon P, Arnould L, Bone-Lepinoy MC, Dusserre L, Martin L, Reynders C, Ancion M, Peiffert D, Leroux A, Hubert P, Delhorme JB, Ghnassia JP, Woronoff AS, Delvenne P, Prétet JL, Bosset JF, Peulen O, Mougin C, Valmary-Degano S, Herfs M

Mod. Pathol.. 2020 Jul 29;:

DNA demethylation agent 5azadC downregulates HPV16 E6 expression in cervical cancer cell lines independently of TBX2 expression.

Perrard J, Morel A, Meznad K, Paget-Bailly P, Dalstein V, Guenat D, Mourareau C, Clavel C, Fauconnet S, Baguet A, Mougin C, Pretet JL

Oncol Lett. 2020 Jan;19(1):1074-1081

[Vaccination against papillomavirus : arguments and evidence of effectiveness].

Prétet JL, Selmani Z, Mougin C, Pepin-Puget L, Lepiller Q

Rev Prat. 2020 Jan;70(1):99-103

[HPV testing in the screening and follow-up of patients with cervical high-grade squamous intraepithelial lesions].

Gonthier C, Desportes C, Pretet JL, Azaïs H, Uzan C, Mergui JL, Canlorbe G

Gynecol Obstet Fertil Senol. 2019 Sep 11;:

Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism.

Paget-Bailly P, Meznad K, Bruyère D, Perrard J, Herfs M, Jung AC, Mougin C, Prétet JL, Baguet A

Sci Rep. 2019 Apr 11;9(1):5938

Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples.

Guenat D, Dalstein V, Mauny F, Saunier M, Briolat J, Clavel C, Riethmuller D, Mougin C, Prétet JL

Papillomavirus Res. 2018 Oct 18;:

Awareness of cervical cancer among women attending an HIV treatment centre: a cross-sectional study from Morocco.

Belglaiaa E, Souho T, Badaoui L, Segondy M, Prétet JL, Guenat D, Mougin C

BMJ Open. 2018 Aug 23;8(8):e020343

Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine.

Bretagne CH, Jooste V, Guenat D, Riethmuller D, Bouvier AM, Bedgedjian I, Prétet JL, Valmary-Degano S, Mougin C

J Gynecol Obstet Hum Reprod. 2018 May 25;:

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.

Herfs M, Roncarati P, Koopmansch B, Peulen O, Bruyere D, Lebeau A, Hendrick E, Hubert P, Poncin A, Penny W, Piazzon N, Monnien F, Guenat D, Mougin C, Prétet JL, Vuitton L, Segers K, Lambert F, Bours V, de Leval L, Valmary-Degano S, Quick CM, Crum CP, Delvenne P

Br. J. Cancer. 2018 Apr 27;:

High Prevalence of Anal Canal High-risk Human Papillomavirus Infection in Patients With Crohn's Disease.

Vuitton L, Jacquin E, Parmentier AL, Crochet E, Fein F, Dupont-Gossart AC, Plastaras L, Bretagne CH, Mauny F, Koch S, Prétet JL, Mougin C, Valmary-Degano S

Clin. Gastroenterol. Hepatol.. 2018 Mar 15;:

Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis.

Guenat D, Hermetet F, Prétet JL, Mougin C

Viruses. 2017 Aug;9(8):

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.

Morel A, Baguet A, Perrard J, Demeret C, Jacquin E, Guenat D, Mougin C, Prétet JL

Oncotarget. 2017 May;:

Human papillomaviruses in colorectal cancers: A case-control study in western patients.

Vuitton L, Jaillet C, Jacquin E, Monnien F, Heberle M, Mihai MI, Lassabe C, Raffoul J, Puyraveau M, Lakkis Z, Lamfichekh N, Picard A, Prétet JL, Mougin C, Valmary-Degano S

Dig Liver Dis. 2017 Apr;49(4):446-450

Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study.

Lacau St Guily J, Rousseau A, Baujat B, Périé S, Schultz P, Barry B, Dufour X, Malard O, Pretet JL, Clavel C, Birembaut P, Franceschi S,

Oral Oncol.. 2017 Apr;67:29-36

Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors.

Guenat D, Deroo O, Magnin S, Chaigneau L, Monnien F, Borg C, Mougin C, Emile JF, Prétet JL

Oncol. Rep.. 2017 Mar;37(3):1671-1681

Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.

Lefevre M, Rousseau A, Rayon T, Dalstein V, Clavel C, Beby-Defaux A, Pretet JL, Soussan P, Polette M, Lacau Saint Guily J, Birembaut P,

Br. J. Cancer. 2017 Jan;116(3):362-369

[Molecular diagnosis of human papillomaviruses (HPV): What test(s) in clinical practice?]

Guenat D, Riethmuller D, Ramanah R, Morel A, Aubin F, Mougin C, Prétet JL

J Gynecol Obstet Biol Reprod (Paris). 2016 Nov;45(9):1009-1019

[Practices and attitudes regarding HPV vaccination among general practitioners from Besançon].

Bouvret P, Mougin C, Prétet JL, Meurisse A, Bonnetain F, Fiteni F

J Gynecol Obstet Biol Reprod (Paris). 2016 Oct;45(8):972-978

Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.

Neumann F, Jégu J, Mougin C, Prétet JL, Guizard AV, Lapôtre-Ledoux B, Bara S, Bouvier V, Colonna M, Troussard X, Trétarre B, Grosclaude P, Velten M, Woronoff AS

Prev Med. 2016 Sep;90:52-8

Efferocytosis of apoptotic human papillomavirus-positive cervical cancer cells by human primary fibroblasts.

Hermetet F, Jacquin E, Launay S, Gaiffe E, Couturier M, Hirchaud F, Sandoz P, Prétet JL, Mougin C

Biol. Cell. 2016 Jul;108(7):189-204

[HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population].

Nahet A, Boublenza L, Hassaine H, Masdoua N, Prétet JL, Belglaiaa E, Mougin C

Bull Cancer. 2016 May;103(5):455-60

Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors.

Tauziéde-Espariat A, Bresson D, Polivka M, Bouazza S, Labrousse F, Aronica E, Pretet JL, Projetti F, Herman P, Salle H, Monnien F, Valmary-Degano S, Laquerrière A, Pocard M, Chaigneau L, Isambert N, Aubriot-Lorton MH, Feuvret L, George B, Froelich S, Adle-Biassette H

J. Neuropathol. Exp. Neurol.. 2016 Feb;75(2):111-20

Validation of Novaprep(®) HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2.

Guenat D, Launay S, Riethmuller D, Mougin C, Prétet JL

Infect. Agents Cancer. 2016 ;11:41

High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.

Luquain A, Belglaiaa E, Guenat D, Vrecko S, Riethmuller D, Valmary-Degano S, Bedgedjian I, Chouham S, Prétet JL, Mougin C

Prev Med. 2015 Dec;81:157-62

BRAF mutation screening in melanoma: is sentinel lymph node reliable?

Nardin C, Puzenat E, Pretet JL, Algros MP, Doussot A, Puyraveau M, Mougin C, Aubin F

Melanoma Res. 2015 May 21.

Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area.

Belglaiaa E, Elannaz H, Mouaouya B, Aksim M, Mercier M, Prétet JL, Chouham S, Mougin C

Infect. Agents Cancer. 2015 ;10:44

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.

Riethmuller D, Jacquard AC, Lacau St Guily J, Aubin F, Carcopino X, Pradat P, Dahlab A, Pretet JL

BMC Public Health. 2015 May 2;15:453

Prevalence of human Papillomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors.

Bellaud G, Gheit T, Pugin A, Prétet JL, Tommasino M, Mougin C, Aubin F

J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1816-20

Screening of human papillomavirus infection in women with systemic sclerosis.

Martin M, Mougin C, Pretet JL, Gil H, Meaux-Ruault N, Puzenat E, Ramanah R, Aubin F, Touze A, Coursaget P, Jacquin E, Magy-Bertrand N

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-145-8

Nouveaux biomarqueurs viraux des lésions du col de l'utérus associées aux papillomavirus humains.

Jacquin É, Guenat D, Riethmuller D, Mougin C, Prétet JL

Virologie (Montrouge). 2014 Aug 1;18(4):211-228

New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer.

Pretet JL, Guenat D, Riethmuller D, Mougin C

Indian J Med Res. 2014 Apr;139(4):487-9.

Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15-23 years.

Baudu A, Pretet JL, Riethmuller D, Chotard M, Mougin C, Mercier M

J Epidemiol Glob Health. 2014 Mar;4(1):35-43

Prevalence of human polyomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors.

Bellaud G, Gheit T, Pugin A, Pretet JL, Tommasino M, Mougin C, Aubin F

J Eur Acad Dermatol Venereol. 2014 Mar 5

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platfor

Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bieche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J

J Mol Diagn. 2014 Jan;16(1):45-55

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.

Beau-Faller M, Prim N, Ruppert AM, Nanni-Metéllus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, de Crémoux P, Solassol J, de Fraipont F, Bièche I, Cayre A, Favre-Guillevin E, Tomasini P, Wislez M, Besse B, Legrain M, Voegeli AC, Baudrin L, Morin F, Zalcman G, Quoix E, Blons H, Cadranel J

Ann. Oncol.. 2014 Jan;25(1):126-31

Isoliquiritigenin induces caspase-dependent apoptosis via downregulation of HPV16 E6 expression in cervical cancer Ca Ski cells.

Hirchaud F, Hermetet F, Ablise M, Fauconnet S, Vuitton DA, Pretet JL, Mougin C

Planta Med. 2013 Nov;79(17):1628-35

Real-time duplex PCR for simultaneous HPV 16 and HPV 18 DNA quantitation.

Jacquin E, Saunier M, Mauny F, Schwarz E, Mougin C, Prétet JL

J. Virol. Methods. 2013 Nov;193(2):498-502

Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Jacquin E, Baraquin A, Ramanah R, Carcopino X, Morel A, Valmary-Degano S, Bravo IG, de Sanjose S, Riethmuller D, Mougin C, Pretet JL

J Clin Microbiol. 2013 Oct;51(10):3207-15

Signature patterns of human papillomavirus type 16 in invasive anal carcinoma.

Valmary-Degano S, Jacquin E, Pretet JL, Monnien F, Girardo B, Arbez-Gindre F, Joly M, Bosset JF, Kantelip B, Mougin C

Hum Pathol. 2013 Jun;44(6):992-1002

[Update on vaccine research. Proceedings of the 15th annual conference on vaccine research organized by the National Foundation for Infectious Diseases].

Aubert M, Beytout J, Callamand P, Cheymol J, Combadiere B, Dahlab A, Denis F, Dodet B, Dommergues MA, Gagneur A, Gaillat J, Gavazzi G, Gras-le-Guen C, Haas H, Hau-Rainsard I, Malvy D, de Monleon JV, Picherot G, Pinquier D, Pretet JL, Pulcini C, Rabaud C, Regnier F, Rogeaux O, Savagner C, Soubeyrand B, Valdiguie M, Weil-Olivier C

Arch Pediatr. 2013 Apr;20(4):449-58

Effect of Infliximab on the UVB-Induced Apoptosis of Keratinocytes Infected by HPV38 E6/E7.

Aubin F, Gheit T, Pretet JL, Tommasino M, Mougin C

ISRN Dermatol. 2013;2013:907189

Presence and persistence of human papillomavirus types 1, 2, 3, 4, 27, and 57 on dermoscope before and after examination of plantar warts and after cleaning.

Penso-Assathiany D, Gheit T, Pretet JL, Aubin A, Tommasino M, Mougin C, Braun R, Chosidow O, Aubin F

J Am Acad Dermatol. 2013 Jan;68(1):185-6

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.

Emile JF, Brahimi S, Coindre JM, Bringuier PP, Monges G, Samb P, Doucet L, Hostein I, Landi B, Buisine MP, Neuville A, Bouche O, Cervera P, Pretet JL, Tisserand J, Gauthier A, Le Cesne A, Sabourin JC, Scoazec JY, Bonvalot S, Corless CL, Heinrich MC, Blay JY, Aegerter P

Med Oncol. 2012 Sep;29(3):1765-72

Human papillomavirus and cardiovascular disease.

Prétet JL, Mercier M, Riethmuller D, Aubin F, Vuitton D, Mougin C

J. Am. Coll. Cardiol.. 2012 Jul;60(1):81-2; author reply 82-3

Apoptotic HPV positive cancer cells exhibit transforming properties.

Gaiffe E, Pretet JL, Launay S, Jacquin E, Saunier M, Hetzel G, Oudet P, Mougin C

PLoS One. 2012;7(5):e36766

A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers.

Magnin S, Viel E, Baraquin A, Valmary-Degano S, Kantelip B, Pretet JL, Mougin C, Bigand M, Girardo B, Borg C, Ferrand C

J Mol Diagn. 2011 Sep;13(5):485-92

Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study.

Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Pretet JL, Denis F

Int J Cancer. 2011 Jul 15;129(2):433-9

Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for th

Beau-Faller M, Degeorges A, Rolland E, Mounawar M, Antoine M, Poulot V, Mauguen A, Barbu V, Coulet F, Pretet JL, Bieche I, Blons H, Boyer JC, Buisine MP, de Fraipont F, Lizard S, Olschwang S, Saulnier P, Prunier-Mirebeau D, Richard N, Danel C, Brambilla E, Chouaid C, Zalcman G, Hainaut P, Michiels S, Cadranel J

J Thorac Oncol. 2011 Jun;6(6):1006-15.

Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study.

St Guily JL, Jacquard AC, Pretet JL, Haesebaert J, Beby-Defaux A, Clavel C, Agius G, Birembaut P, Okais C, Leocmach Y, Soubeyrand B, Pradat P, Riethmuller D, Mougin C, Denis F

J Clin Virol. 2011 Jun;51(2):100-4

Position-referenced microscopy for live cell culture monitoring.

Galeano JAZ, Sandoz P, Gaiffe E, Launay S, Robert L, Jacquot M, Hirchaud F, Pretet JL, Mougin C

. 2011 May 1;2(5):1307-18.

E6 and E7 proteins from different beta-papillomaviruses types do not interfere in UVB-induced apoptosis of HaCaT keratinocytes.

Guerrini JS, Bouvard V, Oswald E, Alonso A, Pretet JL, Tommasino M, Mougin C, Aubin F

Exp Dermatol. 2011 Jan;20(1):71-3

Human papillomavirus genotype distribution in tonsil cancers.

St Guily JL, Clavel C, Okais C, Pretet JL, Beby-Defaux A, Agius G, Birembaut P, Jacquard AC, Leocmach Y, Soubeyrand B, Riethmuller D, Denis F, Mougin C

Head Neck Oncol. 2011 Feb 7;3(1):6.

Position-referenced microscopy for live cell culture monitoring.

Galeano Z JA, Sandoz P, Gaiffe E, Launay S, Robert L, Jacquot M, Hirchaud F, Pretet JL, Mougin C

Biomed Opt Express. 2011 Apr 25;2(5):1307-18.

Rapid dissemination of SIV follows multisite entry after rectal inoculation.

Ribeiro Dos Santos P, Rancez M, Pretet JL, Michel-Salzat A, Messent V, Bogdanova A, Couedel-Courteille A, Souil E, Cheynier R, Butor C

PLoS One. 2011 May 9;6(5):e19493.

Novaprep((R)) Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2.

Pretet JL, Vidal C, Le Bail Carval K, Ramanah R, Carcopino X, Cartier I, Labouyrie E, Kantelip B, Coumes-Marquet S, Riethmuller D, Mougin C

J Clin Virol. 2010 Dec;49(4):286-9

Detection of human papillomavirus DNA in plucked eyebrow hair from HIV-infected patients.

Biver-Dalle C, Gheit T, Drobacheff-Thiebaut C, Vidal C, Tommasino M, Humbert P, Pretet JL, Mougin C, Aubin F

J Invest Dermatol. 2010 Oct;130(10):2499-502

Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells.

Decrion-Barthod AZ, Bosset M, Plissonnier ML, Marchini A, Nicolier M, Launay S, Prétet JL, Rommelaere J, Mougin C

Anticancer Res.. 2010 Oct;30(10):4049-61

Presence and persistence of human papillomavirus types 1, 2, and 4 on emery boards after scraping off plantar warts.

Aubin F, Gheit T, Pretet JL, Tommasino M, Mougin C, Chosidow O

J Am Acad Dermatol. 2010 Jan;62(1):151-3.

Detection of alpha- and beta-human papillomavirus (HPV) in cutaneous melanoma: a matched and controlled study using specific multiplex PCR combined with DNA microarray primer extension.

Ruer JB, Pepin L, Gheit T, Vidal C, Kantelip B, Tommasino M, Pretet JL, Mougin C, Aubin F

Exp Dermatol. 2009 Oct;18(10):857-62

[Expected impact of a quadrivalent HPV vaccine in France]

Riethmuller D, Pretet JL, Denis F, Aubin F, Pradat P, Clavel C, Dachez R, Gondry J, Carcopino X, Mougin C

J Gynecol Obstet Biol Reprod (Paris). 2009 Sep;38(5):389-95

Spatiotemporal activation of caspase-dependent and -independent pathways in staurosporine-induced apoptosis of p53wt and p53mt human cervical carcinoma cells.

Nicolier M, Decrion-Barthod AZ, Launay S, Pretet JL, Mougin C

Biol Cell. 2009 Jun 4;101(8):455-67.

Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Pretet JL

J Clin Microbiol. 2008 Nov;46(11):3678-85

Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV).

Aubin F, Pretet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D

Clin Infect Dis. 2008 Sep 1;47(5):610-5.

Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study.

Pretet JL, Jacquard AC, Saunier M, Clavel C, Dachez R, Gondry J, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D

Gynecol Oncol. 2008 Aug;110(2):179-84

Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China.

Lu XM, Monnier-Benoit S, Mo LZ, Xu SY, Pretet JL, Liu Z, Vuitton DA, Mougin C

Eur J Surg Oncol. 2008 Jul;34(7):765-70

[Importance of human papillomavirus (HPV) screening in the follow-up after CIN2-3 treatment]

Riethmuller D, Gabelle C, Ramanah R, Sautiere JL, Pretet JL, Schaal JP, Kantelip B, Mougin C, Maillet R

J Gynecol Obstet Biol Reprod (Paris). 2008 Jun;37(4):329-37.

[Integrating HPV testing for primary screening?]

Riethmuller D, Ramanah R, Pretet JL, Mougin C

J Gynecol Obstet Biol Reprod (Paris). 2008 Feb;37 Suppl 1:S139-51

Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study.

Pretet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D

Int J Cancer. 2008 Jan 15;122(2):428-32.

Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study.

Pretet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D

Int J Cancer. 2008 Jan 15;122(2):424-7.

HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN.

Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Pretet JL, Birembaut P, Clavel C

Int J Cancer. 2007 Nov 15;121(10):2198-204.

Cervical intraepithelial neoplasia associated with epidermodysplasia verruciformis HPV in an HIV-infected patient: a manifestation of immune restoration syndrome

Mermet I, Guerrini JS, Cairey-Remonnay S, Drobacheff C, Faivre B, Gaillard M, Kantelip B, Pretet JL, Riethmuller D, Aubin F

Eur J Dermatol. 2007 Mar-Apr;17(2):149-52

Virological and carcinogenic aspects of HPV

Pretet JL, Charlot JF, Mougin C

Bull Acad Natl Med. 2007 Mar;191(3):611-23; discussion 623.

Human papillomavirus infection

Aubin F, Pretet JL, Mougin C, Reithmuller D

Ann Dermatol Venereol. 2007 Jan;134(1):94-9.

[Vaccination against human papillomavirus infections].

Pretet JL, Alvarez E, Monnier-Benoit S, Touze A

Rev Prat. 2006 Nov 15;56(17):1914-8.

Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix.

Monnier-Benoit S, Mauny F, Riethmuller D, Guerrini JS, Capilna M, Felix S, Seilles E, Mougin C, Pretet JL

Gynecol Oncol. 2006 Jul;102(1):22-31

Human papillomavirus in melanoma.

Guerrini JS, Pretet JL, Mougin C, Aubin F

Br J Dermatol. 2006 Mar;154(3):572; author reply 573.

High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women.

Pretet JL, Dalstein V, Monnier-Benoit S, Delpeut S, Mougin C

J Clin Virol. 2004 Oct;31(2):140-7.

Detection of cervical precancer and cancer in a hospital population; benefits of testing for human papillomavirus.

Dalstein V, Riethmuller D, Sautiere JL, Pretet JL, Kantelip B, Schaal JP, Mougin C

Eur J Cancer. 2004 May;40(8):1225-32.

Mitochondrial translocation of p53 and mitochondrial membrane potential (Delta Psi m) dissipation are early events in staurosporine-induced apoptosis of wild type and mutated p53 epithelial cells.

Charlot JF, Pretet JL, Haughey C, Mougin C

Apoptosis. 2004 May;9(3):333-43.

High-risk papillomavirus infection is associated with altered antibody responses in genital tract: non-specific responses in HPV infection.

Bard E, Riethmuller D, Meillet D, Prétet JL, Schaal JP, Mougin C, Seillès E

Viral Immunol.. 2004 ;17(3):381-9

Apoptosis participates to liver damage in HSV-induced fulminant hepatitis.

Prétet JL, Pelletier L, Bernard B, Coumes-Marquet S, Kantelip B, Mougin C

Apoptosis. 2003 Dec;8(6):655-63

Delayed viral replication and CD4(+) T cell depletion in the rectosigmoid mucosa of macaques during primary rectal SIV infection.

Couëdel-Courteille A, Prétet JL, Barget N, Jacques S, Petitprez K, Tulliez M, Guillet JG, Venet A, Butor C

Virology. 2003 Nov;316(2):290-301

Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.

Dalstein V, Riethmuller D, Pretet JL, Le Bail Carval K, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C

Int J Cancer. 2003 Sep 1;106(3):396-403.

TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions.

Humbey O, Aubin F, Cairey-Remonnay S, Riethmuller D, Pretet JL, Fest T, Seilles E, Mougin C

Eur. J. Obstet. Gynecol. Reprod. Biol.. 2002 Jun;103(1):60-4

Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions.

Bard E, Riethmuller D, Biichlé S, Meillet D, Prétet JL, Mougin C, Seillès E

J Immunoassay Immunochem. 2002 ;23(2):145-62

[Epidemiology of cervical papillomavirus infections. Recent knowledge].

Mougin C, Dalstein V, Prétet JL, Gay C, Schaal JP, Riethmuller D

Presse Med. 2001 Jun;30(20):1017-23

Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle.

Bernard B, Fest T, Prétet JL, Mougin C

Cell Death Differ.. 2001 Mar;8(3):234-44

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques